Aurora Cannabis Stock (CNSX:ACB) (OTC:ACBFF) - Investor Dashboard

Aurora Cannabis
TSX Venture Exchange: ACB
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 140
Established: 2013
CEO: Terry Booth


Fiscal Year-End: June
License Renewal Month: February
Licenses: 1
Licensed Capacity: 5400 KG
Number of Patients: 12,800
Headquarters: Vancouver, BC

Financials (12/31/16)

Cash on hand: $55.8mm
Fixed Investment: $15.7mm
Shareholders’ Equity: $98.2mm
Revenues – Last Quarter: $3.9mm
Adj. Gross Margin: 65.3%
EPS : -.01

Capital Structure (02/28/17)

Last Equity Financing: 33.3mm units at $2.25
Basic Shares: 343.7mm
Warrants: 28.5mm
Options: 13.1mm
Diluted Shares: 395.9mm

Company Brief

Aurora is one of 30+ licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant in the Country to construct a purpose-built facility, which can now be described as no less than state-of-the-art. Because Alberta is one of the most business friendly provinces in the Country, Aurora is able to operate with lower overhead.

Located in rural Alberta there is no cost for the fresh mountain-fed water used in the facility, and operations take place under the lowest corporate tax rates and power rates in the Country. There is also an abundance of Alberta farm credit programs available to Aurora and a number of Albertan Innovation programs. Aurora is arguably the lowest cost-per-gram licensed producer in Canada.

Product Info

  • Most popular product: TEMPLE
  • 24 Strains used for both flower and oils
  • 10+ Flagship strains
    • THC %: < 1% – 32% (Highest reported)
    • CBD %: < 0.5% – 24% (Highest reported)
    • Types: Indica, Sativa, Hybird, Blend
  • 0 Pesticides and gamma-irradiation
  • $8 Per Gram; $5 / Gram Low Income Pricing
  • Oils available soon subsequent to approval received in January 2017

Growth Strategy

  • Customer experience
    • Differentiated Products
    • 24/7 client care support
    • Same day-delivery and weekend courier
    • Easy to use mobile app
  • Increase # of intermediary partners
  • Dispensary Transition Program
  • Aurora Wellness Centers
  • U.S. / International Expansion, including 19.9% ownership of Cann Group in Australia
  • Quebec expansion with acquisition of Peloton, a late-stage ACMPR


  • Purpose-built facility located on a low-cost, low-energy leased property with access to free water and room for expansion capable of serving 21K patients
  • Plans for state-of-the-art 800K sq. ft. fully automated greenhouse to be built in Alberta, Canada capable of producing 70mm grams per year
  • Only LP with tissue micro-propagation lab
  • Unique Temple strain with CBD tested at 24%
  • Ownership of CanvasRx, the largest operator of cannabis clinics in Canada
  • Same-day delivery in Alberta and innovative mobile ordering app
  • All products certified by third-party testing through Anandia Labs

Institutional Analyst Coverage


GMP Securities

Curated Stories & News

Visit Aurora Cannabis

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Aurora Cannabis is a client of NCV Media, LLC. Read our full disclaimer.

Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.



NCV Media, LLC

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.